We are live on ! Find out more
PP

Paloma Partners Portfolio holdings

AUM $510M
1-Year Est. Return 286.05%
This Fund
S&P 500
This Quarter Est. Return
+5.02%
1 Year Est. Return
+286.05%
3 Year Est. Return
+321.92%
5 Year Est. Return
+284.54%
10 Year Est. Return
+855.7%
AUM
$3.78B
AUM Growth
-$541M
Cap. Flow
-$699M
Cap. Flow %
-18.5%
Top 10 Hldgs %
26.03%
Holding
2,134
New
570
Increased
494
Reduced
496
Closed
467

Top Buys

Rank Stock Value
1
AGN
Allergan plc
AGN
+$28.7M
2
FXE icon
Invesco CurrencyShares Euro Currency Trust
FXE
+$23.2M
3
BIIB icon
Biogen
BIIB
+$20.8M
4
NKE icon
Nike
NKE
+$18.3M
5
IBM icon
IBM
IBM
+$17.2M

Sector Composition

Rank Sector Weight
1 Healthcare 6.62%
2 Industrials 6.54%
3 Financials 6.19%
4 Technology 6.15%
5 Consumer Discretionary 5.62%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
HA
851
DELISTED
Hawaiian Holdings, Inc.
HA
$686K 0.02%
+19,403
New +$671K
CPAY icon
852
Corpay
CPAY
$25.7B
$682K 0.02%
4,772
-4,869
-51% -$715K
AJG icon
853
Arthur J. Gallagher & Co
AJG
$69.1B
$680K 0.02%
16,603
+6,718
+68% +$289K
MAS icon
854
PUT
Masco
MAS
$14.6B
$679K 0.02%
24,000
-150,000
-86% -$4.27M
SYNH
855
DELISTED
Syneos Health, Inc. Class A Common Stock
SYNH
$676K 0.02%
+13,926
New +$619K
LLY icon
856
CALL
Eli Lilly
LLY
$1.08T
$674K 0.02%
+8,000
New +$664K
LLY icon
857
PUT
Eli Lilly
LLY
$1.08T
$674K 0.02%
+8,000
New +$664K
BFAM icon
858
Bright Horizons
BFAM
$4.35B
$673K 0.02%
10,065
-10,469
-51% -$677K
TXT icon
859
CALL
Textron
TXT
$14.9B
$672K 0.02%
16,000
-6,000
-27% -$248K
TXT icon
860
PUT
Textron
TXT
$14.9B
$672K 0.02%
16,000
-6,000
-27% -$248K
UFS
861
DELISTED
DOMTAR CORPORATION (New)
UFS
$672K 0.02%
18,188
-16,924
-48% -$670K
LII icon
862
Lennox International
LII
$15B
$671K 0.02%
5,375
+1,648
+44% +$212K
STRZA
863
DELISTED
Starz - Series A
STRZA
$670K 0.02%
19,992
-31,710
-61% -$1.13M
ITW icon
864
Illinois Tool Works
ITW
$84.1B
$668K 0.02%
7,207
-13,898
-66% -$1.26M
PH icon
865
Parker-Hannifin
PH
$120B
$667K 0.02%
6,885
+3,003
+77% +$304K
SNX icon
866
TD Synnex
SNX
$19.9B
$667K 0.02%
14,822
+5,872
+66% +$271K
BEAV
867
DELISTED
B/E Aerospace Inc
BEAV
$667K 0.02%
15,738
+6,836
+77% +$306K
RESI
868
DELISTED
Front Yard Residential Corporation Common Stock
RESI
$666K 0.02%
53,683
+27,816
+108% +$382K
D icon
869
Dominion Energy
D
$62B
$658K 0.02%
9,744
+380
+4% +$26.2K
YOKU
870
PUT
DELISTED
YOUKU TUDOU INC.(CAYMAN ISLS)
YOKU
$654K 0.02%
+24,100
New +$605K
IP icon
871
International Paper
IP
$22.6B
$653K 0.02%
18,266
-19,871
-52% -$765K
TIVO
872
DELISTED
Tivo Inc
TIVO
$652K 0.02%
39,160
-61,927
-61% -$696K
FLS icon
873
Flowserve
FLS
$8.94B
$651K 0.02%
+15,455
New +$682K
APH icon
874
Amphenol
APH
$185B
$649K 0.02%
49,668
+33,688
+211% +$450K
BDC icon
875
Belden
BDC
$3.97B
$649K 0.02%
+13,616
New +$748K

Similar funds

Paloma Partners's Q4 2015 Portfolio in Review

As of Q4 2015, Paloma Partners held 2,134 positions worth $3.78B, down 13% from $4.32B the previous quarter. Its ten largest holdings account for 26% of the portfolio.

Paloma Partners withdrew a net $699M in Q4 2015, closing 467 positions and reducing 496 holdings. Its most notable exit was SIGMA - ALDRICH CORP, an estimated $48.6M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 6.6% of assets, up from 5.8% a quarter earlier, followed by Industrials and Financials.

Against the trend, Paloma Partners opened a new position in Allergan plc worth $30.1M.

  • Paloma Partners's largest Q4 2015 buy was Allergan plc: 96,344 shares worth $30.1M.
  • Paloma Partners added most to Biogen in Q4 2015, an estimated $20.8M increase.
  • Paloma Partners's biggest Q4 2015 reduction was Regeneron Pharmaceuticals, cutting an estimated $46.2M.
  • Paloma Partners fully exited SIGMA - ALDRICH CORP in Q4 2015, selling an estimated $48.6M.
  • Paloma Partners's ten largest holdings make up 26% of its $3.78B portfolio in Q4 2015.
  • Paloma Partners opened 570 new positions and closed 467 in Q4 2015.
  • Paloma Partners's portfolio value fell 13% quarter-over-quarter to $3.78B.

Based on Paloma Partners's 13F filing for Q4 2015, filed 16 Feb 2016.